Global Amrinon (CAS 60719-84-8) Market Research Report 2021

Amrinon (CAS 60719-84-8), C10H9N3O, the formula weight is 187.2, and its form is yellow crystal powder.
Amrinone is suitable for acute and chronic refractory congestive heart failure caused by various reasons such as ineffective or poorly effective treatment of digitalis, diuretics, and vasodilators.

The global Amrinon (CAS 60719-84-8) market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on Amrinon (CAS 60719-84-8) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Amrinon (CAS 60719-84-8) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Amrinon (CAS 60719-84-8) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
50mg/Vail
100mg/Vail

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Qilu Pharma
Huanglong Pharma
Yichuang Pharma
Zhongbao Pharma
Samarth Lifescience
Florencia Healthcare

Frequently Asked Questions